Treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs. Patients who were treated earlier, it is advisable to prescribe medication after laboratory detection of sensitivity to drug patient isolated mycobacteria.

Infectious-inflammatory processes of different localization, caused by gram-positive and gram-negative microorganisms sensitive to the drug: pneumonia caused by klebsiella, endocarditis, plague, tularemia, brucellosis.

Treatment of cattle, sheep, goats, pigs and horses in diseases of the digestive tract, respiratory organs and urogenital system, skin and soft tissues, caused by microorganisms susceptible to streptomycin.

Prevention of recurrences of life-threatening ventricular tachycardia or ventricular fibrillation, symptomatic ventricular tachycardia; supraventricular tachycardia; heat rhythm disorders in case of resistance to or contraindication of other treatments; heart rhythm disorders attributable to WPW syndrome.Treatment of supraventricular tachycardia to slow down the heart rate or to restore the sinus rhythm in cases of atrial fibrillation and atrial flutter. 
The medication is recommended for patients with ischemic heart disease and/or impaired left ventricular function for managing documented supraventricular tachycardia to control the heart rate in case of atrial fibrillation and atrial flutter.

Induction in anesthesia. As a further means for the base anesthesia (with the subsequent use of analgesics and muscle relaxants). As an additional means for the relief of convulsive states of various etiologies, including causes by the use of a local anesthetic. To reduce intracranial pressure in patients with increased intracranial pressure during mechanical ventilation.

Hepatitis of various origin, cholecystitis, myocarditis, cardiomyopathy associated with metabolic disorders, ischemic heart disease (as an adjunctive treatment) and postoperative complications.

Hepatitis of various origin, cholecystitis, myocarditis, cardiomyopathy associated with metabolic disorders, ischemic heart disease (as an adjunctive treatment) and postoperative complications.

In the complex treatment of ischemic heart disease: angina, myocardial infarction, postinfarction cardiosclerosis; as additional treatment in the treatment of cardiac arrhythmias. In the complex treatment of chronic hepatitis, alcoholic hepatitis, liver fibrosis and cirrhosis.

In the complex treatment of ischemic heart disease: angina, myocardial infarction, postinfarction cardiosclerosis; as additional treatment in the treatment of cardiac arrhythmias. In the complex treatment of chronic hepatitis, alcoholic hepatitis, liver fibrosis and cirrhosis.